Tower Research Capital LLC (TRC) - WEREWOLF THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,029
-41.7%
2,350
-16.9%
0.00%
Q2 2023$8,622
+215450.0%
2,827
+85.5%
0.00%
Q1 2023$4
-73.3%
1,524
-78.7%
0.00%
-100.0%
Q4 2022$15
-100.0%
7,146
+9.4%
0.00%
Q3 2022$30,000
+200.0%
6,531
+178.7%
0.00%
Q2 2022$10,000
-16.7%
2,343
-13.8%
0.00%
Q1 2022$12,000
+50.0%
2,717
+316.7%
0.00%
Q4 2021$8,000
+14.3%
652
+56.0%
0.00%
Q3 2021$7,000
+600.0%
418
+703.8%
0.00%
Q2 2021$1,000520.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders